Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 25 Issue 4, April 2024

Predicting and evaluating drugs for combination therapy

Guo and colleagues present a method known as CM-Drug for the identification of combination drugs that can boost the efficacy of immune checkpoint blockade therapy. They validate this method using melanoma and lung cancer models in mice and explore one hit from their screen in further depth, the thyrotropin-releasing hormone (TRH) analogue taltirelin.

See Guo et al.

Image: Yun Xia. Cover design: Amie Fernandez

Correspondence

Top of page ⤴

Research Highlights

Top of page ⤴

News & Views

  • Granulosomes are novel complexes that feature an unexpected partnership between the tetraspanin CD63 and the inflammasome proteins NLRP3 and ASC. Granulosomes assemble on mast cell granules to propel them along microtubules to the plasma membrane for degranulation.

    • J. Magarian Blander
    • Yuhua Shi
    News & Views
  • Profiling of plasma proteins in individuals with COVID-19 shows that complement activation and myeloid inflammation are major pathways in the pathogenesis of long COVID and identifies distinct profiles of immune dysregulation in individuals with long COVID, highlighting the heterogeneous and diverse nature of this disease.

    • Laura Ceglarek
    • Onur Boyman
    News & Views
  • Understanding normal hematopoiesis is critical to understanding disease. Technological advances are driving insight into human hematopoiesis at unprecedented resolution. Integrating ‘-omics’ datasets with machine learning has yielded a high-resolution map of primary human bone marrow hematopoietic progenitor cells that supports the study of immune cell development, as well as the origins of disease.

    • Kathrin M. Bernt
    News & Views
  • DNA sensing for the purposes of innate immunity is tricky when the DNA sensor can easily become stuck on chromosomes during cell division. The mechanism by which the trapped DNA sensor is degraded — and how this process can be balanced with added immune protection — is now reported.

    • Calvin Jon A. Leonen
    • Hironori Funabiki
    News & Views
  • T cell- and antibody-based immunological protection are generally considered to function together, but data now show how T cells conferred by previous SARS-CoV-2 infection or two-dose vaccination can elicit heterologous protection in mice against subsequent SARS-CoV-2 infection, even in the absence of antibodies.

    • Thi H. O. Nguyen
    • Katherine Kedzierska
    News & Views
Top of page ⤴

Research Briefings

  • Autoantibodies that develop in systemic lupus erythematosus (SLE) can cause long-term cognitive impairment that remains even after the systemic disease becomes quiescent. This study attributes the persistent cognitive symptoms of SLE to a self-sustaining neuroinflammatory process that continues indefinitely unless disrupted — which can be done using medications approved by the US Food and Drug Administration.

    Research Briefing
Top of page ⤴

Review Articles

Top of page ⤴

Letters

Top of page ⤴

Articles

Top of page ⤴

Resources

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links